India’s contract research, development and manufacturing organisation (CRDMO) sector has gained momentum in recent years, but financial performance alone may not determine which companies emerge as long-term winners, according to global brokerage Jefferies.
The brokerage identified six factors that could shape the sector’s long-term prospects: relationships with Big Pharma, integrated capabilities, specialised manufacturing expertise, project pipeline, manufacturing scale and execution.
